Efficacy and safety of posaconazole in prevention of invasive fungal infections during allogeneic hematopoietic stem cell transplantation: a single-center retrospective analysis

Código QR

Efficacy and safety of posaconazole in prevention of invasive fungal infections during allogeneic hematopoietic stem cell transplantation: a single-center retrospective analysis

Objective To investigate the efficacy and safety of posaconazole (PCZ) in the prevention of invasive fungal disease (IFD) during allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods The medical records of 80 patients who received allo-HSCT at our center from March 2017 to March 2...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	ZHANG Yanfang, LOU Shifeng, CHEN Shu, ZHOU KangLUO Yun, LUO Yun, HUANG Xi
Formato:	article
Lenguaje:	ZH
Publicado:	Editorial Office of Journal of Third Military Medical University 2021
Materias:	posaconazole allogeneic hematopoietic stem cell transplantation invasive fungal infection prophylactic antifungal therapy Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/9a353d3030f6441e8221d240721ecae5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Hematopoietic stem cell transplantation: clinical use and perspectives
por: Barriga,Francisco, et al.
Publicado: (2012)

Risk factors for late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: analysis of 227 cases
por: XIONG Yiying, et al.
Publicado: (2021)

The Use of Voriconazole as Primary Prophylaxis for Invasive Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation: A Single Center’s Experience
por: Ali Atoui, et al.
Publicado: (2021)

CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations
por: Takahashi,Hiroshi, et al.
Publicado: (2015)

Iron chelation therapy improves hematopoiesis in patients with hematological malignancy after hematopoietic stem cell transplantation
por: ZENG Cong, et al.
Publicado: (2021)

Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome
por: Sheng-Hsuan Chien, et al.
Publicado: (2021)

Improvement of hematopoietic stem cell transplantation in the targeted therapy era
por: ZHANG Xi, et al.
Publicado: (2021)

Subcutaneous immunoglobulin in allogeneic hematopoietic cell transplant patients: A prospective study of feasibility, safety, and healthcare resource use
por: Ivan Pasic, et al.
Publicado: (2021)

Effect of Amnion-Wrapped Allogenic Nerve Bridging on Peripheral Nerve Injury
por: Zhang,Yan-Ru, et al.
Publicado: (2013)

Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections
por: Wiederhold NP
Publicado: (2015)

Letermovir Prophylaxis and Cytomegalovirus Reactivation in Adult Hematopoietic Cell Transplant Recipients with and without Acute Graft Versus Host Disease
por: Delaney Wolfe, et al.
Publicado: (2021)

Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
por: Yi-Chang Liu, et al.
Publicado: (2021)

Mathematical Modeling of Within-Host, Untreated, Cytomegalovirus Infection Dynamics after Allogeneic Transplantation
por: Elizabeth R. Duke, et al.
Publicado: (2021)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FANCONI ANEMIA; A SINGLE CENTRE EXPERIENCE
por: Tariq Azam Khattak, et al.
Publicado: (2021)

ACTIVATION OF T. GONDII INFECTION AFTER ALLOGENEIC TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS: DEPENDENCE ON TIME OF TRANSPLANTATION AND SEROLOGICAL STATUS OF THE PATIENTS
por: A. B. Chukhlovin, et al.
Publicado: (2015)

A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation
por: Paul J. Martin, et al.
Publicado: (2021)

Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era
por: Sanghee Hong, et al.
Publicado: (2021)

Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
por: F. Yuan, et al.
Publicado: (2021)

CLINICAL EFFECTS OF MESENCHYMAL STROMAL CELLS IN LYMPHOMA PATIENTS WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: E. V. Batorov, et al.
Publicado: (2012)

Donor‐derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation
por: Ryo Hanaki, et al.
Publicado: (2021)

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
por: Yan-Ruide Li, et al.
Publicado: (2021)

Sirolimus versus imatinib in patients with steroid-refractory chronic graft-versus-host disease: a retrospective analysis of a single-center
por: HE Yundi, et al.
Publicado: (2021)

Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients
por: Wei C, et al.
Publicado: (2021)

The Effect of Posaconazole and Isavuconazole on the Pharmacokinetics of Erdafitinib in Beagle Dogs by UPLC-MS/MS
por: Lan-hong Ruan, et al.
Publicado: (2021)

Editorial: The Role of Hematopoietic Progenitors in Immune Regulation and Memory
por: Flora Zavala, et al.
Publicado: (2021)

Haploidentical donor transplant is associated with secondary poor graft function after allogeneic stem cell transplantation: A single‐center retrospective study
por: Wei‐Ran Lv, et al.
Publicado: (2021)

Farmacocinética de posaconazol en la profilaxis y tratamiento de la infección fúngica invasora en niños inmunocomprometidos en un hospital pediátrico
por: Valenzuela,Romina, et al.
Publicado: (2018)

Biology of blood and marrow transplantation journal of the American Society for Blood and Marrow Transplantation.
Publicado: (1995)

Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
por: Donata Backhaus, et al.
Publicado: (2021)

All You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections
por: Rosanne Sprute, et al.
Publicado: (2021)

IMMUNE STATE IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AT LATE TERMS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: N. V. Minaeva, et al.
Publicado: (2014)

Histocompatibility and Immunogenetics in Cord Blood Transplantation
por: Rubinstein,Pablo, et al.
Publicado: (2010)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
por: Mohammadi R, et al.
Publicado: (2021)

Phenotypes, Lung Microbiota and Cytokine Responses in Pneumonia After Hematopoietic Stem Cell Transplantation
por: Hu Y, et al.
Publicado: (2021)

Hepatic sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic cell transplantation: historical and current considerations in Korea
por: Jae-Ho Yoon, et al.
Publicado: (2021)

Differentiation of Yin, Yang and Stasis Syndromes in Severe Aplastic Anemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Their Correlation with Iron Metabolism, cAMP/cGMP, 17-OH-CS and Thyroxine
por: Hu H, et al.
Publicado: (2021)

Trasplante alogénico de precursores hematopoyéticos en pacientes con síndrome de Wiskott-Aldrich
por: Wietstruck P,María Angélica, et al.
Publicado: (2007)

Impact of graft-versus-host disease prophylaxis on immune reconstitution in patients after allogeneic hematopoietic stem cell transplantation
por: E. D. Mikhaltsova, et al.
Publicado: (2021)

Alginate nanoparticles as non-toxic delivery system for miltefosine in the treatment of candidiasis and cryptococcosis
por: Spadari CC, et al.
Publicado: (2019)

Fun(gi)omics: Advanced and Diverse Technologies to Explore Emerging Fungal Pathogens and Define Mechanisms of Antifungal Resistance
por: B. Ball, et al.
Publicado: (2020)